CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 85 filers reported holding CHINOOK THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $67,163,577 | +84.9% | 1,748,141 | +11.4% | 3.59% | +134.1% |
Q1 2023 | $36,317,651 | -4.1% | 1,568,797 | +8.6% | 1.53% | -3.5% |
Q4 2022 | $37,854,546 | +38.5% | 1,444,830 | +3.9% | 1.59% | +40.1% |
Q3 2022 | $27,327,000 | -12.4% | 1,390,000 | -22.1% | 1.14% | -4.4% |
Q2 2022 | $31,206,000 | +33.0% | 1,784,200 | +24.4% | 1.19% | +65.6% |
Q1 2022 | $23,464,000 | +15.3% | 1,434,200 | +15.0% | 0.72% | +82.0% |
Q4 2021 | $20,346,000 | +52.2% | 1,247,468 | +19.1% | 0.39% | +75.1% |
Q3 2021 | $13,366,000 | -2.2% | 1,047,468 | +8.2% | 0.22% | +10.3% |
Q2 2021 | $13,668,000 | +60.0% | 968,023 | +76.1% | 0.20% | +61.9% |
Q1 2021 | $8,541,000 | +2.3% | 549,615 | +4.4% | 0.13% | +5.9% |
Q4 2020 | $8,350,000 | – | 526,455 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Samsara BioCapital, LLC | 5,161,888 | $119,497,707 | 24.70% |
Saturn V Capital Management LP | 506,818 | $11,732,837 | 8.76% |
Octagon Capital Advisors LP | 2,551,703 | $59,071,924 | 8.50% |
Affinity Asset Advisors, LLC | 976,021 | $22,594,886 | 7.46% |
Frazier Life Sciences Management, L.P. | 4,345,559 | $100,599,691 | 7.28% |
Altium Capital Management LP | 305,000 | $7,060,750 | 3.92% |
Deep Track Capital, LP | 3,000,000 | $69,450,000 | 2.85% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 319,989 | $7,407,745 | 2.07% |
Nan Fung Group Holdings Ltd | 113,950 | $2,637,943 | 1.80% |
Nicholas Investment Partners, LP | 972,191 | $22,506,222 | 1.71% |